bearish
The Concerns and Outlook About the Recent Rally in Traditional Chinese Medicine (TCM) Sector
280 Views06 Jan 2022 08:44
The insight mainly analyzed the logic behind the recent rally in TCM sector, the policy impact, the concerns on limited resources, VBP, internationalization, historical problems, etc. and the outlook.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- The Insecure Rebound in Healthcare Sector and the Future Direction of Stock Price (2022)17 Jan 2022
- China Healthcare Weekly (Jan.14) - Impact on Dental Implant VBP, Prediction on 7th National VBP 202216 Jan 2022
- China Healthcare Weekly (Jan.7)-China's Drug Spending,Logic Behind China/US Biotech, Anesthetics VBP09 Jan 2022
- The Concerns and Outlook About the Recent Rally in Traditional Chinese Medicine (TCM) Sector06 Jan 2022
- China Healthcare Weekly (Dec.31)-1st State-Level Device Policy,TCM Guideline,TCM Rally Unsustainable02 Jan 2022
- The CXO/Biotech Plunge and the Afterwards Investment Logic (2022)20 Dec 2021
- Pientzehuang Pharmaceutical Co., Ltd. (600436.CH) 2021Q3 - Concerns Behind The "Double Top Secret"25 Oct 2021
x